Dailies Total 1 Sphere Contact Lenses
How Does DT1 Sphere Perform in Those Who Previously Dropped Out of Contact Lenses Due to Comfort or Dryness?
1 other identifier
interventional
60
1 country
4
Brief Summary
CL discomfort is a complex phenomenon that has been defined by the Tear Film and Ocular Surface Society in their seminal report on contact lens (CL) discomfort as a condition that results in "episodic or persistent adverse ocular sensation related to lens wear, either with or without visual disturbance resulting from reduced compatibility between the CL and the environment, which can lead to decreased wearing time and discontinuation of CL wear." A recent review by Pucker and Tichenor found that CL discomfort was the top reason for established CL wears to cease wearing CLs. This same review alarmingly found that the frequency of CL dropout was about 20% across the many studies aimed at evaluating this condition, which is surprising given the introduction of better soft CL materials and daily disposable CLs over the past 20 plus years. Dailies Total1 (DT1), which is a relatively new daily disposable CL, is a commonly used trouble shooting CL for patients who have failed with other CLs because DT1 utilizes advanced material technology that is specifically aimed at improving CL comfort. While DT1 is commonly used in these struggling patients, the literature currently lacks a targeted study aimed at understanding the frequency of successfully refitting CL dropouts into this advanced CL. Thus, the purpose of this study is to determine the frequency that past CL wearers who failed because of dryness or CL discomfort who can comfortable wear DT1.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedStudy Start
First participant enrolled
May 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedOctober 1, 2024
September 1, 2024
1.3 years
February 4, 2022
August 20, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale (VAS) Contact Lenses Comfort Scores
The median visual analog scale (VAS) scores at the 1-month visit (-50 to +50 scale with scores greater than 0 being comfortable).
1 month
Secondary Outcomes (1)
Likert Questionnaire
One Month
Study Arms (1)
Dailies Total1
EXPERIMENTALAll participants will be asked to wear Dailies Total1 for the duration of this study.
Interventions
Eligibility Criteria
You may qualify if:
- Adults 18-40
- Past contact lens wearers who have best corrected 20/20 visual acuity or better
- Participants will have had to have worn contact lenses for at least 1 year in the past
- Dropped out of contact lenses in the past 2 years do to discomfort or dryness
- Scores of 3 or less on the SPEED questionnaire
- Be able to be refit into Dailies Total1 Sphere contact lenses
- Provide a glasses prescription that is less than 3-years-old
You may not qualify if:
- Past rigid contact lens wearers
- A past history of being diagnosed with dry eye or ocular allergies
- Known systemic health conditions that are known to alter tear film physiology
- History of viral eye disease
- History of ocular surgery
- History of severe ocular trauma
- History of corneal dystrophies or degeneration
- Having active ocular infection or inflammation
- Currently using isotretinoin-derivatives or ocular medication
- Pregnant or breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- Alcon Researchcollaborator
Study Sites (4)
University of Alabama at Birmingham
Birmingham, Alabama, 35213, United States
Kannarr Eye Care
Pittsburg, Kansas, 66762, United States
ProCare Vision Center
Granville, Ohio, 43023, United States
The Southern College of Optometry
Memphis, Tennessee, 38104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Andrew Pucker, OD, PhD
- Organization
- University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 4, 2022
First Posted
February 15, 2022
Study Start
May 23, 2022
Primary Completion
August 30, 2023
Study Completion
August 30, 2023
Last Updated
October 1, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-09